2019 IPC Events
Join us at these events to expand your knowledge about psoriasis.
Thursday, February 28, 2019 2:00 pm – 5:00 pm
Program chair: Arnon D. Cohen, Israel Program faculty: Robert Bissonnette, Canada; Jennifer Murase, USA; Jashin Wu, USA
Thursday, April 4, 2019 1:00 pm - 5:00 pm
Friday, April 5, 2019 9:00 am - 5:00 pm
Program chairs: Mahira El Sayed, Egypt; Mohamed El-Komy, Egypt International faculty: Chris Griffiths, UK; Peter van de Kerkhof, the Netherlands
Thursday, April 25, 2019 9:30 pm – 11:30 am
Program chair: Peter van de Kerkhof, the Netherlands Program faculty: Errol Prens, the Netherlands; Marieke Seyger, the Netherlands; Fernando Valenzuela, Chile; Ron Vender, Canada
Thursday, May 2, 2019 12:00 - 5:00 pm
Friday, May 3, 2019 9:00 am - 5:00 pm
Program chairs: Claudia de la Cruz, Chile; Ricardo Romiti, Brazil International faculty: Alan Menter, USA ; Peter van de Kerkhof, the Netherlands Regional faculty: Matías Maskin, Argentina; Fernando Valenzuela, Chile
Friday, May 3, 2019 2:30 pm - 4:00 pm
Program chairs: Cristina Echeverría, Argentina & César Gonzalez, Colombia Program faculty: Paula Luna, Argentina & Enrique Rivas, Guatemala
SOCIETY FOR INVESTIGATIVE DERMATOLOGY ANNUAL MEETING | CHICAGO, ILLINOIS, US
Wednesday, May 8, 2019 9:00 am - 1:00 pm
Program chairs: April Armstrong, USA; Johann Gudjonsson, USA; Nehal Mehta, USA Program faculty: Hafid Ait-Oufella, France; Joel Gelfand, USA; Marlies Wakkee, the Netherlands
This program is supported in part by an educational grant from AbbVie.
Monday, June 10, 2019 1:30 pm – 4:30 pm
Program chair: Jonathan Barker, UK Program faculty: Hervé Bachelez, France; Lars Iversen, Denmark; Kelly Cordoro, USA; Omid Zagari, Iran
Wednesday, September 18, 2019 2:00 pm – 6:00 pm
Program chairs: Michel Gilliet, Switzerland; Johann Gudjonsson, USA; Jörg Prinz, Germany Program faculty: Hervé Bachelez, France; Francesca Capon, UK; Chyung-Ru Wang, USA; Poster Presentations: Ian Catlett, USA; Athanasios Niaouris, UK; Lorenzo Pasquali, Sweden; Ashley Rider, UK; Enikö Pivarcsi Sonkoly, Sweden; Christian Thoma, Germany
This program is sponsored in part by Boehringer-Ingelheim.
Wednesday, October 9, 2019 9:00 am - 12:00 pm
Program chairs: Catherine Smith, UK; Bruce Strober, USA Program faculty: Lone Skov, Denmark; Robert Strohal, Austria; Tiago Torres, Portugal
This program is sponsored in part by Samsung Bioepis and Biogen.
November 8, 2019 3:30 pm – 5:30 pm
Program Chairs: Jonathan Barker, UK; Christopher Griffiths, UK Program faculty: Hervé Bachelez, France; Masamoto Murakami, Japan; Kazumitsu Sugiura, Japan
congress coverage EADV 2019 Read the psoriasis highlights from the EADV 2019 congress learn more
now available COVID-19 Psoriasis Resource Center Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve explore now
Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve
Latest news Commentary: Genetic studies suggest that inflammatory skin diseases increase the risk of COVID-19.February 08, 2021Professor Francesca Capon provides a commentary An article recently published in the Journal of Allergy and Clinical Immunology1 suggests that diseases such as psoriasis and atopic dermatitis increase the risk of COVID-19 by approximately 50%. In the Lab with IPC Councilor Nicole WardFebruary 03, 2021Dr. Ward is a Professor of Dermatology and Neurosciences at Case Western Reserve University and University Hospitals Case Medical Center in Cleveland, Ohio. She has spent the past 16 years developing mouse models to help identify the cellular and molecular mechanisms underlying inflammatory skin disease and its associated comorbidities. Commentary: Cytokine inhibitors have a low prevalence of SARS-CoV-2 seroconversionFebruary 02, 2021n a recent publication in Nature Communications1 a team from Friedrich-Alexander University in Germany described their findings from a cross-sectional population cohort study on the prevalence of anti-SARS-CoV-2 immunoglobulin G (IgG) in patients with chronic immune-mediated inflammatory diseases (IMIDs) on cytokine-blocking treatments. This patient cohort was compared against subjects with IMIDs, not on cytokine inhibitors, health care workers, and healthy controls. The findings from this study showed that patients with IMID on cytokine inhibitors had a lower prevalence of anti-SARS-CoV-2 IgG response compared to the other three cohorts. To assess whether this could be accounted for by differences in social exposure between the groups, the investigators assessed exposure risk variables in the four groups and found those to be similar between the two IMID groups and less than that of health care workers. Introducing the IPC Academy OnlineJanuary 28, 2021IPC Academy Online, a free online learning platform, has been designed to provide expert insight, timely research, and practical information to dermatologists anywhere in the world to improve the care of psoriasis patients. More News